- Article
Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
- Sally Miller,
- Shashank Kulkarni,
- Alex Ciesielski,
- Spyros P. Nikas,
- Ken Mackie,
- Alexandros Makriyannis and
- Alex Straiker
Nearly half a century has passed since the demonstration that cannabis and its chief psychoactive component Δ9-THC lowers intraocular pressure (IOP). Elevated IOP remains the chief hallmark and therapeutic target for glaucoma, a condition that...

